Tirzepatide reduced weight, A1c, and insulin dose in type 1 diabetes in a small randomized controlled trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/first-randomized-trial-tirzepatide-t1d-shows-benefits-2025a1000poc?src=rss
Author :
Publish date : 2025-09-25 10:10:00
Copyright for syndicated content belongs to the linked Source.
